Complications
Unopposed oestrogen replacement therapy is associated with an increased incidence of:
- endometrial hyperplasia and endometrial carcinoma
- abnormal bleeding patterns
There is evidence of an increased risk of breast cancer if there has been more than 5 years of post-menopausal HRT.
There is a demonstrable increased risk of thrombosis (though very slight) with modern HRT formulations.
Related pages
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.